Sonntag, 28. April 2024
Navigation öffnen
Anzeige:
Wefra Programatic
 
JOURNAL ONKOLOGIE – STUDIE
BOREAS

KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment

Rekrutierend

NCT-Nummer:
NCT03662126

Studienbeginn:
Januar 2019

Letztes Update:
28.04.2023

Wirkstoff:
KRT-232, Best Available Therapy (BAT)

Indikation (Clinical Trials):
Polycythemia Vera, Primary Myelofibrosis, Polycythemia, Thrombocytosis, Thrombocythemia, Essential

Geschlecht:
Alle

Altersgruppe:
Erwachsene (18+)

Phase:
-

Sponsor:
Kartos Therapeutics, Inc.

Collaborator:
-

Kontakt

Studienlocations
(3 von 191)

Klinikum Rechts der Isar der Technischen Universität München Apotheke
81675 München
(Bayern)
GermanyRekrutierend» Google-Maps
Universitätsklinikum Aachen
52074 Aachen
GermanyAktiv, nicht rekrutierend» Google-Maps
Universitaetsklinikum Essen
45147 Essen
(Nordrhein-Westfalen)
GermanyRekrutierend» Google-Maps
Hauttumorzentrum am Universitätsklinikum Halle
Ernst-Grube-Straße 40
06120 Halle (Saale)
(Sachsen-Anhalt)
DeutschlandRekrutierend» Google-Maps
Gemeinschaftspraxis Haematologie - Onkologie - Hauptstelle
01307 Dresden
(Sachsen)
GermanyRekrutierend» Google-Maps
Technische Universität Dresden
01307 Dresden
(Sachsen)
GermanyRekrutierend» Google-Maps
Universitätsklinikum Jena
07747 Jena
(Thüringen)
GermanyRekrutierend» Google-Maps
Charité Universitätsmedizin Berlin
13353 Berlin
(Berlin)
GermanyRekrutierend» Google-Maps
UKE - Universitätsklinikum Hamburg-Eppendorf
20251 Hamburg
(Hamburg)
GermanyRekrutierend» Google-Maps
Universitätsmedizin der Johannes Gutenberg Universität Mainz
Mainz
(Rheinland-Pfalz)
GermanyAktiv, nicht rekrutierend» Google-Maps
Darmzentrum Stauferklinikum Schwäbisch Gmünd
Wetzgauer Straße 85
73557 Mutlangen
DeutschlandRekrutierend» Google-Maps
Praxis für Hämatologie und Onkologie
66113 Saarbrücken
(Saarland)
GermanyRekrutierend» Google-Maps
The Kirklin Clinic of UAB Hospital
35294 Birmingham
United StatesAktiv, nicht rekrutierend» Google-Maps
University of Southern California Norris Comprehensive Cancer Center
90033 Los Angeles
United StatesAktiv, nicht rekrutierend» Google-Maps
Stanford Cancer Center - Palo Alto
94305 Stanford
United StatesAktiv, nicht rekrutierend» Google-Maps
Innovative Clinical Research Institute
90603 Whittier
United StatesAbgeschlossen» Google-Maps
University Cancer Institute
33426 Boynton Beach
United StatesZurückgezogen» Google-Maps
Northwestern University Feinberg School of Medicine
60611 Chicago
United StatesAbgeschlossen» Google-Maps
University of Illinois at Chicago
60612 Chicago
United StatesRekrutierend» Google-Maps
Dana-Farber Cancer Institute
02215 Boston
United StatesZurückgezogen» Google-Maps
Washington University School of Medicine
63110 Saint Louis
United StatesRekrutierend» Google-Maps
Brookdale University Hospital and Medical Center
11212 Brooklyn
United StatesRekrutierend» Google-Maps
New York Presbyterian/Weill Cornell Medical Center
10021 New York
United StatesZurückgezogen» Google-Maps
The Ohio State University Comprehensive Cancer Center
43210 Columbus
United StatesAbgeschlossen» Google-Maps
Oregon Health and Science University
97239 Portland
United StatesAbgeschlossen» Google-Maps
Avera Cancer Institute
57105 Sioux Falls
United StatesRekrutierend» Google-Maps
Vanderbilt University Medical Center
37203 Nashville
United StatesRekrutierend» Google-Maps
The University of Texas MD Anderson Cancer Center
77030 Houston
United StatesRekrutierend» Google-Maps
Medical College of Wisconsin - Froedtert Hospital
53226 Milwaukee
United StatesRekrutierend» Google-Maps
Instituto Medico Alexander Fleming
Buenos Aires
ArgentinaRekrutierend» Google-Maps
Hospital Privado - Centro Medico de Cordoba - Oncology
X5016KEH Córdoba
ArgentinaRekrutierend» Google-Maps
South Eastern Private Hospital
3174 Noble Park
AustraliaRekrutierend» Google-Maps
Centro de oncologia Leonardo da Vinci
60140-025 Fortaleza
BrazilRekrutierend» Google-Maps
UNICAMP - Universidade Estadual de Campinas Hemocentro
13083 Campinas
BrazilRekrutierend» Google-Maps
Fundacao Doutor Amaral Carvalho
17210-120 Jau
BrazilRekrutierend» Google-Maps
Hospital de Clinicas de Porto Alegre - Centro de Pesquisa Clinica
90035-903 Porto Alegre
BrazilRekrutierend» Google-Maps
Associação Educadora São Carlos AESC - Hospital Mãe de Deus - Centro de Pesquisa
90880-480 Porto Alegre
BrazilRekrutierend» Google-Maps
Instituto de Ensino e Pesquisa São Lucas
01236-030 Sao Paulo
BrazilRekrutierend» Google-Maps
Hospital A C Camargo - Fundacao Antonio Prudente
01509-900 Sao Paulo
BrazilRekrutierend» Google-Maps
Hospital das Clínicas da Universidade de São Paulo
05403-000 Sao Paulo
BrazilRekrutierend» Google-Maps
Instituto D'or de Pesquisa e Ensino
04502-001 São Paulo
BrazilRekrutierend» Google-Maps
Instituto COI São Paulo
1321001 São Paulo
BrazilRekrutierend» Google-Maps
University Multiprofile Hospital for Active Treatment Dr. Georgi Stranski, Pleven
Pleven
BulgariaRekrutierend» Google-Maps
University Multiprofile Hospital for Active Treatment Sveti Georgi, Plovdiv
Plovdiv
BulgariaRekrutierend» Google-Maps
Military Medical Academy, Multiprofile for active treatment, Sofia
1606 Sofia
BulgariaRekrutierend» Google-Maps
Acibadem City Clinic Tokuda Hospital, Sofia
Sofia
BulgariaRekrutierend» Google-Maps
Specialized Hospital for Active Therapy of Hematological Disorders
Sofia
BulgariaRekrutierend» Google-Maps
University Multiprofile Hospital for Active Treatment Alexandrovska, Sofia
Sofia
BulgariaZurückgezogen» Google-Maps
University Multiprofile Hospital for Active Treatment Saint Ivan Rilski, Sofia
Sofia
BulgariaRekrutierend» Google-Maps
Princess Margaret Cancer Center
M5G 2M9 Toronto
CanadaAktiv, nicht rekrutierend» Google-Maps
Clinical Hospital Centre Osijek
10000 Zagreb
CroatiaRekrutierend» Google-Maps
Vseonecma fakultni nemocrince V Praze
Nové Město
CzechiaRekrutierend» Google-Maps
Fakultní Nemocnice Olomouc
779 00 Olomouc
CzechiaZurückgezogen» Google-Maps
Centre Hospitalier Universitaire D'Amiens (Hopital Sud) - Hématologie Clinique
80054 Amiens
FranceRekrutierend» Google-Maps
Center Hospitalier Universitaire d'Angers
49933 Cedex 09 Angers
FranceRekrutierend» Google-Maps
C.H de la Côte Basque - Serviv
64100 Bayonne
FranceRekrutierend» Google-Maps
Centre Hospitalier Regional Universitaire Brest Hopital Morvan
29609 Brest Cedex
FranceRekrutierend» Google-Maps
Centre Hospitalier Universitaire of Caen Normandie - Côte de Nacre
14000 Caen
FranceAktiv, nicht rekrutierend» Google-Maps
Centre Hospitalier Universitaire de Nîmes
30029 Cedex 9 Nîmes
FranceAktiv, nicht rekrutierend» Google-Maps
Centre Hospitalier Universitaire de Poitiers
Poitiers
FranceRekrutierend» Google-Maps
Institut Universitaire du Cancer de Toulouse Oncopole
31059 Toulouse
FranceRekrutierend» Google-Maps
Hopital Paul Brousse - Aphp Hôpitaux Universitaires Paris Su
94800 Villejuif
FranceRekrutierend» Google-Maps
University General Hospital of Ioannina
45500 Ioánnina
GreeceRekrutierend» Google-Maps
University Campus of Patras - Hematology
26504 Patras
GreeceRekrutierend» Google-Maps
AHEPA General Hospital of Thessaloniki
54636 Thessaloníki
GreeceRekrutierend» Google-Maps
Prince of Wales Hospital - Medicine
Shatin
Hong KongRekrutierend» Google-Maps
Somogy Megyei Kaposi Mór Oktató Kórház
7400 Kaposvár
HungaryZurückgezogen» Google-Maps
Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókórház
4400 Nyíregyháza
HungaryRekrutierend» Google-Maps
Markusovszky Egyetemi Oktatókórház
H-9700 Szombathely
HungaryRekrutierend» Google-Maps
Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet
Budapest
HungaryRekrutierend» Google-Maps
Debreceni Egyetem Orvos es Egeszsegtudomanyi Centrum
4032 Debrecen
HungaryAbgeschlossen» Google-Maps
Hadassah Medical Organisation
91120 Jerusalem
IsraelRekrutierend» Google-Maps
Western Galilee Hospital - Nahariya
22100 Nahariya
IsraelRekrutierend» Google-Maps
Rabin Medical Center - Beilinson Hospital
49100 Petah Tikva
IsraelRekrutierend» Google-Maps
Tel Aviv Sourasky Medical Center - Oncology
6423906 Tel Aviv
IsraelRekrutierend» Google-Maps
Assaf Harofeh Medical Center - Hematology
7030000 Zerifin
IsraelRekrutierend» Google-Maps
A.O. San Gerardo di Monza - L'Ospedale San Gerardo di Monza e l'Università di Milano
20900 Monza
ItalyRekrutierend» Google-Maps
PO Civile SS.Antonio e Biagio
15121 Alessandria
ItalyRekrutierend» Google-Maps
AOU Ospedali Riuniti Umberto I G.M. Lancisi G. Salesi
60123 Ancona
ItalyRekrutierend» Google-Maps
A.O.di Bologna Policl.S.Orsola
41038 Bologna
ItalyRekrutierend» Google-Maps
Azienda Ospedaliero Universitaria Policlinico - Vittorio Emanuele
95123 Catania
ItalyRekrutierend» Google-Maps
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS
Meldola
ItalyRekrutierend» Google-Maps
Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda
20122 Milano
ItalyRekrutierend» Google-Maps
ASST Grande Ospedale Metropolitano Niguarda
20162 Milano
ItalyRekrutierend» Google-Maps
Azienda Ospedaliera Ospedali Riuniti Marche Nord - Pesaro
61121 Pesaro
ItalyRekrutierend» Google-Maps
Arcispedale S. Maria Nuova, AO di Reggio Emilia
42123 Reggio Emilia
ItalyRekrutierend» Google-Maps
Policlinico Universitario Agostino Gemelli
00168 Roma
ItalyRekrutierend» Google-Maps
A.O. Citta della Salute e della Scienza di Torino
10126 Torino
ItalyRekrutierend» Google-Maps
Inje University Busan Paik Hospital
47392 Busan
Korea, Republic ofRekrutierend» Google-Maps
Kyungpook National University Hospital
41944 Daegu
Korea, Republic ofRekrutierend» Google-Maps
Yeungnam University Medical Center
42415 Daegu
Korea, Republic ofRekrutierend» Google-Maps
Keimyung University Dongsan Medical Center
42601 Daegu
Korea, Republic ofRekrutierend» Google-Maps
CHA Bundang Medical Center, CHA University
Seongnam-si Seongnam-si
Korea, Republic ofRekrutierend» Google-Maps
Seoul National University Hospital
03080 Seoul
Korea, Republic ofRekrutierend» Google-Maps
Samsung Medical Center
06351 Seoul
Korea, Republic ofRekrutierend» Google-Maps
The Catholic University of Korea, Seoul St. Mary's Hospital
6591 Seoul
Korea, Republic ofRekrutierend» Google-Maps
Hospital of Lithuanian University of Health Sciences Kaunas
LT-50161 Kaunas
LithuaniaRekrutierend» Google-Maps
Universidad Autonoma de Nuevo Leon (UANL) - Hospital Universitario "Dr. Jose Eleuterio Gonzalez
64460 Monterrey
MexicoRekrutierend» Google-Maps
Instituto Mexicano del Seguro Social
64180 Monterrey
MexicoRekrutierend» Google-Maps
Oaxaca Site Management Organization OSMO
6800 Oaxaca
MexicoRekrutierend» Google-Maps
Sociedad de Metabolismo y Corazón S.C. - Oncology
91910 Veracruz
MexicoRekrutierend» Google-Maps
Perpetual Succour Hospital - Hemat/Transfusion Med
6000 Cebu City
PhilippinesRekrutierend» Google-Maps
University of the Philippines - Philippine General Hospital
1000 Manila
PhilippinesRekrutierend» Google-Maps
Dolnośląskie Centrum Transplantacji Komórkowych z Krajowym Bankiem Dawców Szpiku
53-439 Wrocław
PolandRekrutierend» Google-Maps
Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. Ks. B. Markiewicza
36-200 Brzozow
PolandAktiv, nicht rekrutierend» Google-Maps
Samodzielny Publiczny Zakład Opieki Zdrowotnej Zespół Szpitali Miejskich
41-500 Chorzów
PolandRekrutierend» Google-Maps
Szpital Uniwersytecki nr 2 im dr. Jana Biziela
86-168 Bydgoszcz
PolandRekrutierend» Google-Maps
Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie
20-081 Lublin
PolandZurückgezogen» Google-Maps
SPZOZ MSWiA z Warminsko - Mazurskim Centrum Onkologii
Olsztyn
PolandRekrutierend» Google-Maps
Clinical Research Center Spółka z Ograniczoną Odpowiedzialnością Medic-R sp. k.
60-848 Poznań
PolandZurückgezogen» Google-Maps
Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka w Slupsku Sp. z o.o.
76-200 Słupsk
PolandRekrutierend» Google-Maps
H. Infante Dom Pedro. Centro Hospitalar do Baixo Vouga
3814-501 Aveiro
PortugalRekrutierend» Google-Maps
Instituto Português de Oncologia de Coimbra
3000-075 Coimbra
PortugalRekrutierend» Google-Maps
H. São Francisco Xavier-Centro Hospitalar Lisboa Ocidental
1495-005 Lisboa
PortugalRekrutierend» Google-Maps
Champalimaud Cancer Center
1400-038 Lisbon
PortugalRekrutierend» Google-Maps
Cen Med de Diagn si Trat Amb NEOMED
500283 Brasov
RomaniaRekrutierend» Google-Maps
Spitalul Clinic Colentina
020125 Bucharest
RomaniaRekrutierend» Google-Maps
Institutul Oncologic "Prof. Dr. Ion Chiricuta"
400015 Cluj-Napoca
RomaniaRekrutierend» Google-Maps
Spitalul Clinic Municipal Filantropia Craiova
200143 Craiova
RomaniaRekrutierend» Google-Maps
Institutul Regional de Oncologie Iasi
700483 Iaşi
RomaniaRekrutierend» Google-Maps
Spitalul Clinic Municipal de Urgenta Timisoara
300079 Timişoara
RomaniaRekrutierend» Google-Maps
Spitalul Clinic Judetean de Urgenta Tg Mures
540136 Târgu-Mureş
RomaniaRekrutierend» Google-Maps
Clinical oncological dispensary
644013 Omsk
Russian FederationZurückgezogen» Google-Maps
Saint-Petersburg SMU I.P.Pavlov
197089 St Petersburg
Russian FederationZurückgezogen» Google-Maps
Oncologic dispensary of Komi Republic
167904 Syktyvkar
Russian FederationZurückgezogen» Google-Maps
Hospital Universitari Germans Trias i Pujol
08916 Badalona
SpainRekrutierend» Google-Maps
Hospital Universitario de Gran Canaria Doctor Negrin
35010 Las Palmas De Gran Canaria
SpainRekrutierend» Google-Maps
Hospital Universitario Puerta de Hierro - Majadahonda
28222 Majadahonda
SpainAktiv, nicht rekrutierend» Google-Maps
Hospital Universitario Vall d'Hebrón
08035 Barcelona
SpainRekrutierend» Google-Maps
Hospital de La Santa Creu i Sant Pau
8041 Barcelona
SpainRekrutierend» Google-Maps
Hospital San Pedro de Alcantara
1003 Cáceres
SpainRekrutierend» Google-Maps
Hospital Universitario Virgen de la Victoria
29010 Málaga
SpainRekrutierend» Google-Maps
Hospital Universitario Son Espases
07120 Palma de Mallorca
SpainRekrutierend» Google-Maps
Complejo Hospitalario de Navarra - H. de Navarra, Hematología C/ de Irunlarrea, 3, Pamplona
31008 Pamplona
SpainRekrutierend» Google-Maps
Hospital Universitario de Salamanca
37007 Salamanca
SpainRekrutierend» Google-Maps
Hospital Universitario Doctor Peset
46017 Valencia
SpainRekrutierend» Google-Maps
National Taiwan University Hospital
100 Taipei City
TaiwanRekrutierend» Google-Maps
Chang Gung Medical Foundation - ChiaYi Chang Gung Memorial Hospital - Chiayi Branch
Chiayi City
TaiwanRekrutierend» Google-Maps
Kaohsiung Medical University - Chung-Ho Memorial Hospital
807 Kaohsiung
TaiwanRekrutierend» Google-Maps
China Medical University Hospital
40447 Taichung
TaiwanRekrutierend» Google-Maps
Ramathibodi Hospital - Mahidol University - Hematology
10400 Bangkok
ThailandRekrutierend» Google-Maps
Thammasat University Hospital
12120 Khlong Luang
ThailandRekrutierend» Google-Maps
Srinagarind Hospital (KhonKaen University)
40002 Khon Kaen
ThailandRekrutierend» Google-Maps
Sakarya Research and Training Hospital
54100 Adapazarı
TurkeyRekrutierend» Google-Maps
Ankara University Faculty of Medicine
06500 Ankara
TurkeyRekrutierend» Google-Maps
Gazi University Medical Faculty
06500 Ankara
TurkeyRekrutierend» Google-Maps
Gaziantep University Faculty of Medicine
27100 Gaziantep
TurkeyRekrutierend» Google-Maps
Inonu University Turgut Ozal Medical Center
44280 Malatya
TurkeyRekrutierend» Google-Maps
Mersin University Medical Faculty
33110 Mersin
TurkeyRekrutierend» Google-Maps
Ondokuz Mayis University Medical Faculty - Hematology
55280 Samsun
TurkeyRekrutierend» Google-Maps
University Hospitals Birmingham NHS Foundation Trust
Birmingham
United KingdomAktiv, nicht rekrutierend» Google-Maps
NHS Greater Glasgow and Clyde
Glasgow
United KingdomAktiv, nicht rekrutierend» Google-Maps
Guy's and Saint Thomas' NHS Foundation Trust
SE1 9RT London
United KingdomAktiv, nicht rekrutierend» Google-Maps
Oxford University Hospitals NHS Foundation Trust
Oxford
United KingdomAktiv, nicht rekrutierend» Google-Maps
Alle anzeigen

Studien-Informationen

Brief Summary:

This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the

treatment of patients with myelofibrosis (MF) who no longer benefit from treatment with a JAK

inhibitor. Inhibition of MDM2 is a novel mechanism of action in MF.

This study will be conducted in 2 phases. Phase 2 will determine the KRT-232 recommended dose

and dosing schedule; Phase 3 will test KRT-232 vs Best Available Therapy (BAT). Patients in

the Phase 3 part of the study will be randomized 2:1 to receive either KRT-232 (Arm 1) or BAT

(Arm 2). The BAT administered will be determined by the treating physician, with the option

to "cross-over" to KRT-232 treatment after 6 months of BAT or if the disease worsens at any

time.

Ein-/Ausschlusskriterien

Inclusion Criteria:

- Confirmed diagnosis of PMF, post-PV MF or post-ET MF (WHO)

- High, intermediate-2, or intermediate-1 risk Dynamic International Prognostic System

(DIPSS)

- Failure of prior treatment with JAK inhibitor

- ECOG ≤ 2

Exclusion Criteria:

- Prior splenectomy

- Splenic irradiation within 3 months prior to randomization

- History of major hemorrhage or intracranial hemorrhage within 6 months prior to

randomization

- History of stroke, reversible ischemic neurological defect or transient ischemic

attack within 6 months prior to randomization

- Prior MDM2 inhibitor therapy or p53-directed therapy

- Prior allogeneic stem-cell transplant or plans for allogeneic stem cell transplant

- History of major organ transplant

- Grade 2 or higher QTc prolongation (> 480 milliseconds per NCI-CTCAE criteria, version

5.0)

Studien-Rationale

Primary outcome:

1. (Part A Only) Spleen Volume Reduction (SVR) (Time Frame - 24 weeks):
The proportion of subjects achieving a ≥ 35% spleen volume reduction (SVR) from Baseline to Week 24, as assessed by magnetic resonance imaging (MRI) or computed tomography (CT) scan

2. (Part B Only) Spleen Volume Reduction (SVR) (Time Frame - 24 Weeks):
The proportion of subjects achieving SVR of ≥ 35% at Week 24 by MRI/CT scan (central review)

Secondary outcome:

1. (Part A only) Improvement in Total Symptom Score (TSS) (Time Frame - 48 weeks):
The proportion of subjects who have at least a 50% reduction from Baseline to Week 24 and Week 48 in the total symptom score as measured by the modified MPN-SAF v2.0

2. (Part B only) Improvement of Total Symptom Score (TSS) (Time Frame - 24 Weeks):
The proportion of subjects who have at least a 50% reduction from Baseline to Week 24 in the total symptom score as measured by the MF-SAF v4.0

3. (Part B only) Overall Survival (OS) (Time Frame - 48 months):
Time from randomization to death from any cause

4. (Part B only) Progression free survival (PFS) (Time Frame - 48 months):
Time from randomization to either first occurrence of disease progression or death due to any cause

5. (Part B Only) Overall Spleen Volume Reduction (SVR) (Time Frame - 48 months):
The proportion of subjects in each arm achieving SVR of ≥ 35% at any time by MRI/CT scan (central review)

6. (Part B Only) Spleen Response Duration (Time Frame - 48 months):
Time from initial SVR of ≥ 35% by MRI/CT (central review) until the first occurrence of disease progression

7. (Part B Only) Rate of conversion from RBC transfusion dependent to independent (Time Frame - 24 weeks):
The proportion of subjects who have RBC transfusion independence at week 24

Studien-Arme

  • Experimental: Part A Cohort 1
    KRT-232 120 mg by mouth once daily for Days 1-7, off treatment for Days 8-21 (21-day cycles)
  • Experimental: Part A Cohort 2
    KRT-232 240 mg by mouth once daily for Days 1-7, off treatment for Days 8-21 (21-day cycles)
  • Experimental: Part A Cohort 3
    KRT-232 240 mg by mouth once daily for Days 1-7, off treatment for Days 8-28 (28-day cycles)
  • Experimental: Part A Cohort 4b
    KRT-232 240 mg by mouth once daily for Days 1-5, off treatment for Days 6-28 (28-day cycles)
  • Experimental: Part B Arm 1 KRT-232
    KRT-232 240 mg by mouth once daily for Days 1-7, off treatment for Days 8-28 (28-day cycles)
  • Active Comparator: Part B Arm 2 Best Available Therapy
    Best available therapy at the discretion of the investigator, on a 28-day cycle.

Geprüfte Regime

  • KRT-232:
    KRT-232, administered by mouth
  • Best Available Therapy (BAT):
    Best available therapy options include: hydroxyurea chemotherapy or supportive care (including but not limited to corticosteroids and androgens; JAK inhibitors not allowed).

Quelle: ClinicalTrials.gov


Sie können folgenden Inhalt einem Kollegen empfehlen:

"KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment"

Bitte tragen Sie auch die Absenderdaten vollständig ein, damit Sie der Empfänger erkennen kann.

Die mit (*) gekennzeichneten Angaben müssen eingetragen werden!

Die Verwendung Ihrer Daten für den Newsletter können Sie jederzeit mit Wirkung für die Zukunft gegenüber der MedtriX GmbH - Geschäftsbereich rs media widersprechen ohne dass Kosten entstehen. Nutzen Sie hierfür etwaige Abmeldelinks im Newsletter oder schreiben Sie eine E-Mail an: rgb-info[at]medtrix.group.